Rhumbline Advisers Acer Therapeutics Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding ACER
# of Institutions
1Shares Held
365Call Options Held
0Put Options Held
0About Acer Therapeutics Inc.
- Ticker ACER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,100,000
- Description
- Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...